White label – Pompe disease - ClinicalTrials.eu

A Study of Fluvoxamine for Reducing Fatigue in Patients with Post-COVID Condition

Recruiting

3 1 1
Investigated Diseases:
- Post-acute COVID-19 syndrome
A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Recruiting

3 1 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- Midazolam
- Esketamine
A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Recruiting

3 1 1 1
Investigated Drugs:
+9
A study of guanabenz acetate for children with vanishing white matter disease who started treatment in early childhood

Recruiting

1 1 1
Investigated Drugs:
- Guanabenz Acetate
A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes

Recruiting

3 1
Investigated Diseases:
- Diabetes mellitus
Investigated Drugs:
- Teplizumab
+4
A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

Recruiting

3 1 1
Investigated Diseases:
- Clear cell renal cell carcinoma
Investigated Drugs:
+2
A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

Recruiting

2 1
Investigated Diseases:
- Cardiomyopathy
- Hypertrophic cardiomyopathy
+3
Study of gemcitabine, cisplatin, and pembrolizumab before and after surgery compared to surgery alone for patients with bile duct cancer

Recruiting

4 1 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
A Study of Belimumab to Help Identify Safe Kidney Transplant Matches in Patients with High Antibody Levels Against Donor Tissue Types

Recruiting

2 1 1 1
Investigated Drugs:
- Belimumab
A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

Recruiting

4 1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies